ArticleCancer causes & control : CCC2025
The effect of cultural and linguistic diversity on the timeliness of prostate cancer treatment: a registry-based retrospective cohort study.
Article in Cancer causes & control : CCC, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo examine associations between culturally and linguistically diverse (CALD) status and definitive treatment delay among individuals diagnosed with intermediate- or high-risk prostate cancer (PCa) in Victoria, Australia.
methodsData were sourced from the Victorian Prostate Cancer Outcomes Registry (PCOR-Vic). Individuals with index diagnoses of intermediate- or high-risk PCa (February 2009-August 2022) who were receiving PCa-directed definitive treatment (radical prostatectomy or radiotherapy) were included. CALD status was defined as being born in non-English-speaking countries versus mainly English-speaking countries (MESC) or Australia. Additionally, using preferred spoken language, CALD individuals were categorized into English-speaking CALD and non-English-speaking CALD individuals. Binary logistic regression was used to examine associations between CALD status and definitive treatment delay (> 90 days from diagnosis to treatment). Mediation analysis was undertaken using generalized structural equation modeling.
resultsOf 13,625 participants, 2,455 were from CALD backgrounds (18%). Nine per cent of 2,455 CALD individuals preferred speaking languages other than English. Median days to definitive treatment were longer for non-English-speaking CALD (92) compared to Australian-born (64) individuals. Non-English-speaking CALD individuals experienced significantly (adjusted odds ratio = 2.54, 95% confidence interval = 1.92-3.38) greater treatment delay than Australian-born individuals, adjusted for sociodemographic and clinical factors. The association between CALD status and definitive treatment delay was fully mediated by non-English-speaking CALD individuals being diagnosed mostly at public institutions.
conclusionNon-English-speaking-CALD individuals experienced greater delays in the definitive treatment of intermediate- and high-risk PCa than Australian-born individuals, which is largely explained by the type of diagnosing health institution. More timely treatment for non-English-speaking-CALD will require less delay in public hospitals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.